首页> 外文期刊>Frontiers in Immunology >Editorial: Roles of Ion Channels in Immune Cells
【24h】

Editorial: Roles of Ion Channels in Immune Cells

机译:社论:离子通道在免疫细胞中的作用

获取原文
       

摘要

The Editorial on the Research Topic Roles of Ion Channels in Immune Cells Ion channels are critical membrane proteins controlling a wide variety of cellular signaling events in many different cell types. In classical excitable cells, voltage-sensitive ion channels have well-described roles in the regulation of action potentials and contraction events. In non-excitable cells such as circulating or tissue-resident cells of the immune system, ion channels have lesser described roles in controlling cell biology. However, through enhanced pharmacological tools and gene knockouts, we are now beginning to appreciate the plethora of cellular events in immune cells that are controlled by a variety of ion channels ( 1 ). The goal of this research topic was to highlight some of the recent advances in understanding which ion channels are important and are under investigation for novel therapeutics. This collection of six articles covers microglia, myeloid cells, and lymphocytes and provides updates and insights into the roles of various channels in these cells. Mortadza and colleagues review the latest evidence supporting a functional role for transient receptor potential melastatin (TRPM) 2 ion channels in the immune system ( Syed Mortadza et al. ). TRPM2 ion channels are activated by increases in reactive oxygen species (ROS) leading to Ca~(2+)signals in a range of immune cells. The authors discuss the use of TRPM2 knockout mice revealing an important role in the immune system and inflammatory diseases. Based on these studies in mouse models, the authors highlight a negative role for TRPM2 in colitis, ischemia-/reperfusion-mediated tissue damage, and neuropathic and inflammatory pain. They also discuss the importance of TRPM2 in inflammatory signaling including NLRP3 inflammasome activation leading to inflammatory cytokine production including bioactive interleukin (IL)-1β and chemokine-dependent dendritic cell function. Overall, the review demonstrates the importance of TRPM2 as a future therapeutic target for the treatment of inflammatory disease. Stebbing and colleagues provide a mini-review of numerous ion channels expressed in microglia ( Stebbing et al. ). Ligand-gated channels belonging to P2X and N -methyl- d -aspartate (NMDA) receptor families respond to the neurotransmitters adenosine triphosphate (ATP) and glutamate, respectively. These are involved in the sensing of local microenvironments within the central nervous system and can affect microglial activation states through modulation of intracellular Ca~(2+)levels. In addition, K~(+)channels are also implicated in microglial responses including proliferation, nitric oxide generation, and cytokine secretion and, as such, are potential therapeutic targets for increasing neuroprotection in neurodegenerative disorders such as Alzheimer’s disease. Through an original research article, Ferreira and colleagues describe the regulation of the intermediate conductance Ca~(2+)-activated K~(+)channel, KCa3.1, by cyclic guanosine monophosphate (cGMP)-dependent protein kinase (PKG) via a pathway involving ROS and Ca~(2+)/calmodulin-dependent protein kinase II (CaMKII) in microglia ( Ferreira et al. ) KCa3.1 is widely expressed in immune cells, but knowledge of KCa3.1 in microglia is hitherto limited. Through pharmacological approaches, and the use of the rat MLS-9 microglial cell line and alternative-activated primary rat microglia, the authors demonstrate that elevation in cGMP activates PKG to promote mitochondrial ROS formation. This in turn stimulates endoplasmic reticulum Ca~(2+)release, which subsequently binds to calmodulin to both open the KCa3.1 channel and activate CaMKII to increase KCa3.1 activity through a second, unknown mechanism. The authors propose that this process may serve as a positive feedback mechanism to promote KCa3.1-dependent responses in microglia under conditions such as oxidative stress. Moving to the adaptive immune system, Davenport and colleagues have reviewed the current understanding of the Ca_(V)1 subfamily of L-type voltage-gated Ca~(2+)-channels expressed by lymphocytes ( Davenport et al. ). The authors discuss the evidence supporting the expression of Ca_(V)1 ion channels in immune cells including a rare genetic disease (Timothy Syndrome) that suggests a role for Ca_(V)1.2 in human immune responses. Evidence for Ca_(V)1 function in B lymphocytes is largely supported by pharmacological studies, and the authors present further evidence for the expression of Ca_(V)1 ion channels in B lymphocytes using a Ca_(V)1.3 deficient chicken DT40 B cell line. It is concluded that Ca_(V)1 channels play an important role in the immune system; however, there are many unanswered questions particularly surrounding the potential activation mechanism of immune Ca_(V)1 channels. Nohara and colleagues review the current understanding of the complex orchestration of Ca~(2+)responses in T lymphocytes and recent advances in understanding store-operated c
机译:关于离子通道在免疫细胞中的作用的研究主题社论离子通道是控制许多不同细胞类型中各种细胞信号事件的关键膜蛋白。在经典的可激发细胞中,电压敏感离子通道在调节动作电位和收缩事件中具有重要作用。在非兴奋性细胞(例如免疫系统的循环或组织驻留细胞)中,离子通道在控制细胞生物学中的作用较少。然而,通过增强的药理学工具和基因敲除,我们现在开始认识到免疫细胞中受多种离子通道控制的大量细胞事件(1)。该研究主题的目的是突出了解一些最新的进展,以了解哪些离子通道很重要并且正在针对新型疗法进行研究。这六篇文章的集合涵盖了小胶质细胞,髓样细胞和淋巴细胞,并提供了有关这些细胞中各种通道作用的更新和见解。 Mortadza及其同事回顾了支持免疫系统中瞬时受体电位褪黑素(TRPM)2离子通道功能作用的最新证据(Syed Mortadza等)。 TRPM2离子通道被活性氧(ROS)的增加激活,从而导致一系列免疫细胞中的Ca〜(2+)信号。作者讨论了TRPM2基因敲除小鼠在免疫系统和炎症性疾病中的重要作用。基于在小鼠模型中的这些研究,作者强调了TRPM2在结肠炎,缺血/再灌注介导的组织损伤以及神经性和炎性疼痛中的负作用。他们还讨论了TRPM2在炎症信号传导中的重要性,包括NLRP3炎症小体激活导致炎症细胞因子的产生,包括生物活性白介素(IL)-1β和趋化因子依赖性树突状细胞功能。总的来说,该综述证明了TRPM2作为治疗炎性疾病的未来治疗靶标的重要性。 Stebbing及其同事对小胶质细胞中表达的众多离子通道进行了简要回顾(Stebbing等人)。属于P2X和N-甲基-d-天冬氨酸(NMDA)受体家族的配体门控通道分别响应神经递质三磷酸腺苷(ATP)和谷氨酸。这些参与中枢神经系统内局部微环境的感知,并可以通过调节细胞内Ca〜(2+)水平影响小胶质细胞的激活状态。此外,K〜(+)通道也与小胶质细胞反应有关,包括增殖,一氧化氮的产生和细胞因子的分泌,因此,它们是增加神经退行性疾病(如阿尔茨海默氏病)中神经保护作用的潜在治疗靶标。 Ferreira及其同事通过原始研究文章描述了环鸟苷单磷酸(cGMP)依赖性蛋白激酶(PKG)通过以下途径调节中间电导Ca〜(2+)激活的K〜(+)通道KCa3.1。小胶质细胞中涉及ROS和Ca〜(2 +)/钙调蛋白依赖性蛋白激酶II(CaMKII)的途径(Ferreira et al。)KCa3.1在免疫细胞中广泛表达,但迄今为止对小胶质细胞中KCa3.1的了解仍然有限。通过药理学方法,以及使用大鼠MLS-9小胶质细胞系和替代激活的原代大鼠小胶质细胞,作者证明cGMP升高会激活PKG促进线粒体ROS的形成。反过来,这会刺激内质网Ca〜(2+)释放,后者随后与钙调蛋白结合,从而打开KCa3.1通道并通过第二个未知机制激活CaMKII以增加KCa3.1活性。作者提出,该过程可作为正反馈机制,以促进小胶质细胞在氧化应激条件下的KCa3.1依赖性反应。转向适应性免疫系统后,Davenport及其同事回顾了对淋巴细胞表达的L型电压门控Ca〜(2+)通道的Ca_(V)1亚家族的最新认识(Davenport等)。作者讨论了支持Ca_(V)1离子通道在免疫细胞中表达的证据,包括罕见的遗传性疾病(提莫西综合症),提示Ca_(V)1.2在人类免疫应答中的作用。药理研究在很大程度上支持了B淋巴细胞中Ca_(V)1功能的证据,并且作者提供了使用缺乏Ca_(V)1.3的鸡DT40 B细胞在B淋巴细胞中表达Ca_(V)1离子通道的进一步证据。线。结论是Ca_(V)1通道在免疫系统中起重要作用。但是,有许多悬而未决的问题,特别是围绕免疫Ca_(V)1通道的潜在激活机制。 Nohara及其同事回顾了当前对T淋巴细胞Ca〜(2+)响应的复杂编排的理解以及在理解存储操纵性c的最新进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号